Vectus Biosystems progresses its human trials with lead cardiovascular drug candidate VB0004
0
ASX:VBS
Watch the video above for detailed insights and analysis.
Video Details
Featured Companies: ASX:VBS
Recorded:
Stay Ahead
Get the latest market insights and analysis delivered to your inbox.